Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Anna Genell"'
Autor:
Göran Wålinder, Anna Genell, Gunnar Juliusson, Ronald Svensson, Antonio Izarra Santamaria, Jacob Crafoord, Kristina Carlson, Dorota Knut‐Bojanowska, Ljupco Veskovski, Birgitta Lauri, Johan Lund, Ingemar Turesson, Markus Hansson, Cecilie Hveding Blimark, Hareth Nahi
Publikováno v:
Cancer Reports, Vol 5, Iss 11, Pp n/a-n/a (2022)
Abstract Background We wanted to evaluate if health care for multiple myeloma (MM) patients is equal in different regions of Sweden. Aim To study differences in survival for MM depending on health care region and early use of modern treatment. Method
Externí odkaz:
https://doaj.org/article/ffd053207c734b989745cde79bf3b206
Autor:
Kari Lenita Falck Moore, Ingemar Turesson, Anna Genell, Tobias W. Klausen, Dorota Knut-Bojanowska, Louise Redder, Ingigerdur Sverrisdottir, Jonathan Thorsen, Annette J. Vangsted, Cecilie H. Blimark
Publikováno v:
Haematologica, Vol 108, Iss 6 (2022)
The prevalence of multiple myeloma (MM) is increasing in Nordic countries and the rest of the western world. Patients aged ≥75 years at diagnosis constitute an increasing proportion of all MM patients, but are underrepresented in randomized clinica
Externí odkaz:
https://doaj.org/article/b417fd552d464582913af276e4294f7d
Autor:
Frida Smith, Lisa Vaughn, Andreas Hellström, Erik Eriksson, Katrín Ásta Gunnarsdóttir, Anna Genell, Carina Mannefred, Thomas Björk-Eriksson
Publikováno v:
BMJ Open Quality, Vol 10, Iss 4 (2021)
Objective Kraftens Hus is the first support centre in Sweden designed by and for people affected by cancer, including patients, family, friends, staff members and local community representatives (collectively ‘stakeholders’). The purpose of this
Externí odkaz:
https://doaj.org/article/431d89e03caa41c1a0c0ab422bea0750
Autor:
Cecilie Hveding Blimark, Ingemar Turesson, Anna Genell, Lucia Ahlberg, Bo Björkstrand, Kristina Carlson, Karin Forsberg, Gunnar Juliusson, Olle Linder, Ulf-Henrik Mellqvist, Hareth Nahi, Sigurdur Y. Kristinsson, for the Swedish Myeloma Registry
Publikováno v:
Haematologica, Vol 103, Iss 3 (2018)
Epidemiology and outcome of myeloma are mainly reported from large university centers and collaborative groups, and do not represent ‘real-world’ patients. The Swedish Myeloma Registry is a prospective population-based registry documenting charac
Externí odkaz:
https://doaj.org/article/6f15e192a08c48359e3dba0422453691
Autor:
Dorota Knut-Bojanowska, Anna Genell, Ingemar Turesson, Cecilie Blimark, Louise Redder, Ingigerdur Sverrisdottir, Kari Lenita Falck Moore, Annette Juul Vangsted, Tobias Wirenfeldt Klausen
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 21:S127-S128
Background Elderly multiple myeloma (MM) patients are underrepresented in randomized clinical trials (RCTs). Prospective registries provide insight into real-world patient characteristics, treatment and outcome. The Danish Multiple Myeloma Registry (
Autor:
Cecilie Blimark, Anna Genell, Gunnar Juliusson, Ulf-Henrik Mellqvist, Sigurður Yngvi Kristinsson, Olle Linder, Lucia Ahlberg, Ingemar Turesson, Kristina Carlson, Karin Forsberg, Hareth Nahi, Bo Björkstrand
Publikováno v:
Haematologica
Epub ahead of print
Epidemiology and outcome of myeloma are mainly reported from large university centers and collaborative groups, and do not represent ‘real-world’ patients. The Swedish Myeloma Registry is a prospective population-based re
Epidemiology and outcome of myeloma are mainly reported from large university centers and collaborative groups, and do not represent ‘real-world’ patients. The Swedish Myeloma Registry is a prospective population-based re
Autor:
Frida Smith, Ulf Lönqvist, Daniel McLinden, Herman Nilsson-Ehle, Thomas Björk-Eriksson, Hege Garelius, Katrín Ásta Gunnarsdóttir, Anna Genell, Lisa M. Vaughn
Publikováno v:
International journal for quality in health care : journal of the International Society for Quality in Health Care. 31(7)
Quality problem or issue Within healthcare, policy documents are often used to strategically standardize, streamline or change how general health issues are managed for a specific patient group or treatment. Despite significant effort in developing p
Autor:
Sigurdur Y. Kristinsson, Ronald Svensson, Forsberg Karin, Olle Linder, Kristina Carlson, Anna Genell, Gunnar Juliusson, Ulf-Henrik Mellqvist, Hareth Nahi, Cecilie Blimark, Katarina Uttervall, Markus Hansson, Göran Wålinder, Bo Björkstrand, Ingemar Turesson
Publikováno v:
European journal of haematology. 99(3)
Solitary plasmacytoma (SP) and plasma cell leukemia (PCL) are uncommon (3-6%) types of plasma cell disease. The risk of progression to symptomatic multiple myeloma (MM) is probably important for the outcome of SP. PCL is rare and has a dismal outcome
Autor:
Hareth Nahi, Birgitta Lauri, Olle Linder, Karin Forsberg, Johan Lund, Dorota Knut-Bojanowska, Kristina Carlson, Cecilie Blimark, Ronald Svensson, Ingemar Turesson, Anna Genell, Gunnar Juliusson, Ljupco Vesskovski, Signe Danielsson
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 19:e209
Publikováno v:
BMC Medical Research Methodology, Vol 9, Iss 1, p 56 (2009)
BMC Medical Research Methodology
BMC Medical Research Methodology
Background In epidemiological studies researchers use logistic regression as an analytical tool to study the association of a binary outcome to a set of possible exposures. Methods Using a simulation study we illustrate how the analytically derived b